PBAC backs new PBS listing for drosperinone-only pill
New MHT options and biosimilars for osteoporosis also have the nod from the committee.
The PBAC has recommended a listing for the drospirenone-only contraceptive pill, acknowledging it is important for women to have a range of affordable options.
At its November meeting, the committee recommended an unrestricted listing for once-daily drospirenone 4mg (Slinda), which has been available on private script for $80 a month since 2021.
